Effect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis

被引：0
|
作者：
Nakamura, T
Liu, J
Morii, H
Huang, Q
Zhu, H
Qu, Y
Hamaya, E
Thiebaud, D
机构：
[1] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka 807, Japan
[2] Gen Hosp PLA, Beijing, Peoples R China
[3] Osaka City Univ, Osaka 558, Japan
[4] Shanghai Peoples Hosp 6, Shanghai, Peoples R China
[5] Shanghai Huadong Hosp, Shanghai, Peoples R China
[6] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
BONE | 2005年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S430 / S431
页数：2
相关论文
共 50 条
  • [21] Raloxifene is an effective option for the prevention of vertebral fractures associated with postmenopausal osteoporosis
    不详
    Drugs & Therapy Perspectives, 2004, 20 (11) : 1 - 5
  • [22] Cumulative Yearly Effects of Raloxifene on the Risk of Vertebral Fractures and Invasive Breast Cancer in Postmenopausal Women with Osteoporosis
    Wong, Mayme
    Liu, Chunhua
    Qu, Yongming
    Helt, Cameron
    Stock, John L.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (06): : 1226 - 1226
  • [23] Mood effect of raloxifene in postmenopausal women
    Jarkova, NB
    Martenyi, F
    Masanauskaite, D
    Walls, EL
    Smetnik, VP
    Pavo, I
    MATURITAS, 2002, 42 (01) : 71 - 75
  • [24] Assessment of adherence to treatment of postmenopausal osteoporosis with raloxifene and/or alfacalcidol in postmenopausal Japanese women
    Itsuo Gorai
    Yaku Tanaka
    Shin Hattori
    Yasuhisa Iwaoki
    Journal of Bone and Mineral Metabolism, 2010, 28 : 176 - 184
  • [25] Assessment of adherence to treatment of postmenopausal osteoporosis with raloxifene and/or alfacalcidol in postmenopausal Japanese women
    Gorai, Itsuo
    Tanaka, Yaku
    Hattori, Shin
    Iwaoki, Yasuhisa
    JOURNAL OF BONE AND MINERAL METABOLISM, 2010, 28 (02) : 176 - 184
  • [26] Treatment of Postmenopausal Women with Osteoporosis or Low Bone Density with Raloxifene
    P. J. Meunier
    E. Vignot
    P. Garnero
    E. Confavreux
    E. Paris
    S. Liu-Leage
    S. Sarkar
    T. Liu
    M. Wong
    M. W. Draper
    Osteoporosis International, 1999, 10 : 330 - 336
  • [27] The effect of raloxifene on bone marrow adipose tissue and bone turnover in postmenopausal women with osteoporosis
    Beekman, Kerensa M.
    Veldhuis-Vlug, Annegreet G.
    den Heijer, Martin
    Maas, Mario
    Oleksik, Ania M.
    Tanck, Michael W.
    Ott, Susan M.
    van't Hof, Rob J.
    Lips, Paul
    Bisschop, Peter H.
    Bravenboer, Nathalie
    BONE, 2019, 118 : 62 - 68
  • [28] Adverse event risk assessment of raloxifene in postmenopausal women with osteoporosis
    Chlebowski, RT
    Cauley, JA
    Disch, D
    Secrest, RJ
    Mershon, JL
    OBSTETRICS AND GYNECOLOGY, 2004, 103 (04): : 102S - 102S
  • [29] EFFECT OF RALOXIFENE ON SERUM LEVELS OF OSTEOPROTEGERIN IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: 3 MONTHS RESULTS
    Munoz-Torres, M.
    CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S81 - S81
  • [30] Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene
    Meunier, PJ
    Vignot, E
    Garnero, P
    Confavreux, E
    Paris, E
    Liu-Leage, S
    Sarkar, S
    Liu, T
    Wong, M
    Draper, MW
    OSTEOPOROSIS INTERNATIONAL, 1999, 10 (04) : 330 - 336
12345